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Objectives:Metabolic syndrome is common among patients having coronary artery bypass grafting. However,
it remains unclear whether it has a significant impact on postoperative complications. We aimed to deter-
mine whether metabolic syndrome negatively influences the postoperative outcomes of coronary artery
bypass grafting.
Methods: We enrolled 1183 patients who had coronary artery bypass grafting at Juntendo University Hospital
between 1984 and 1992. Patients were categorized by the presence or absence of metabolic syndrome using
the modified National Cholesterol Education Program Adult Treatment Panel III definition with body mass index
in the place of waist circumference. Multivariate analysis was performed to assess the relationships between pre-
operative presence of metabolic syndrome and postoperative outcomes.
Results: Metabolic syndrome was present in 551 (46.6%) patients and absent in 632 (53.4%). Postoperative
stroke occurred in 4.7% of patients with metabolic syndrome and 2.1% of patients without metabolic syndrome
(P<.0001). Postoperative acute renal failure occurred in 3.8% of patients with metabolic syndrome and 1.1% of
patients without metabolic syndrome. On multivariate analysis, metabolic syndrome had odds ratios of 2.47
(95% confidence interval 1.22–4.99; P ¼ .012) for postoperative stroke and 3.81 (95% confidence interval
1.42–10.3; P ¼ .008) for postoperative acute renal failure.
Conclusions: This study showed the clinical importance of metabolic syndrome with respect to postoperative
stroke and acute renal failure in patients having coronary artery bypass grafting. Like many established risk factors
for postoperative complications,metabolic syndrome should be recognized as a novel risk factor for adverse events.
Acquired Cardiovascular Disease Kajimoto et alMetabolic syndrome is highly prevalent in patients having
coronary artery bypass grafting (CABG). However, a few
studies have investigated the relationship between metabolic
syndrome and perioperative outcome of CABG.1,2 There-
fore, the goal of this study was to investigate whether preop-
erative presence of metabolic syndrome is associated with
adverse outcomes after CABG.
METHODS
Patients
Preoperative data from patients who had isolated CABG at Juntendo
University Hospital between January 1984 and December 1992 were en-
tered into an institutional structured database. This study was performed
according to the ethics policies of the institution and was approved by the
Internal Review Board. All CABG procedures were performed under con-
ventional cardiopulmonary bypass with crystalloid cardioplegic solution,
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and cardioplegic arrest. Demographic data (including age, gender, and
body mass index [BMI]), coronary risk factors (blood pressure on admis-
sion; fasting levels of total cholesterol, low-density lipoprotein cholesterol,
high-density lipoprotein [HDL] cholesterol, triglycerides, and plasma glu-
cose; smoking history; and family history of coronary artery disease), med-
ication use, and operative parameters were prospectively recorded.
Metabolic syndrome was diagnosed if patients had 3 or more of the fol-
lowing 5 criteria, based on a modified National Cholesterol Education Pro-
gram Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III) (NCEP-ATP III) defini-
tion3: obesity, defined as BMI 25 kg/m2 based on the established Japanese
criteria for obesity,4 rather than waist circumference as in the NCEP-ATP III
definition (waist circumference data were unavailable), triglycerides  150
mg/dL; HDL cholesterol< 40 mg/dL for men,< 50 mg/dL for women;
blood pressure  130/85 mm Hg or treatment with antihypertensive medi-
cation; and fasting blood glucose 100 mg/dL or treatment with oral hypo-
glycemics or insulin. Each patient was further categorized based on the
presence of coronary risk factors. Diabetes mellitus was defined as fasting
plasma glucose levels  126 mg/dL or as a requirement for treatment
with oral hypoglycemic medication or insulin. Hypertension was defined
as a systolic blood pressure  140 mm Hg, a diastolic blood pressure 
90 mm Hg, or a requirement for treatment with specific antihypertensive
medication. Chronic kidney disease (CKD) was defined as glomerular filtra-
tion rate<60 mL $ min1 $ 1.73 m2, as calculated by the Cockcroft-Gault
equation, without dialysis treatment. Peripheral artery disease was defined
as a history of claudication, previous vascular procedure, or evidence of
femoral or abdominal vascular sounds on physical examination.
Outcomes
The incidences of postoperative adverse outcomes were obtained from
our institutional structured database. Postoperative adverse outcomesrgery c March 2009
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DAbbreviations and Acronyms
ARF ¼ acute renal failure
BMI ¼ body mass index
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
CKD ¼ chronic kidney disease
HDL ¼ high-density lipoprotein
NCEP-ATP III ¼ National Cholesterol Education
Program Expert Panel on
Detection, Evaluation, and
Treatment of High Blood
Cholesterol in Adults
(Adult Treatment Panel III)
OR ¼ odds ratio
assessed in this study were in-hospital death, stroke, acute renal failure
(ARF), myocardial infarction, respiratory insufficiency, mediastinitis, and
new onset of atrial fibrillation within the 30 postoperative days. In-hospital
death was defined as death in the hospital from any cause. Stroke was de-
fined as a transient or persistent new central neurologic deficit occurring
within 24 hours after surgery. ARF was defined as the need for dialysis or
as a1.0 mg/dL increase in postoperative serum creatinine relative to base-
line in patients not requiring dialysis. Myocardial infarction was defined as
new Qwaves on the electrocardiogram (transluminal myocardial infarction)
or elevated creatine kinase-MB fraction (>4%) within 48 hours after sur-
gery. Respiratory insufficiency was defined as the need for postoperative
mechanical ventilatory support for longer than 72 hours. Mediastinitis
was defined as a deep sternal wound infection associated with fever and ster-
nal wound instability. Atrial fibrillation was defined as the occurrence of any
atrial fibrillation during hospitalization for the index surgery. Patients on
preoperative dialysis were excluded in the analysis of ARF. Low-output
syndrome was defined as the use of inotropic agents or intra-aortic balloon
pump support, or both, to maintain a cardiac index of<2.0 L $min1 $m2.
Statistical Analysis
In comparing patient characteristics, categorical data were tabulated as
frequencies and percentages, and continuous variables are expressed as
means  standard deviations. These data were analyzed using chi-square
test or Student t test. The effect of metabolic syndrome on incidences of
postoperative adverse outcomes after CABGwas first determined using uni-
variate analysis. Outcomes with P<.25 in the univariate analysis were then
analyzed using a multivariate logistic model. Covariates with P<.25 in the
univariate (chi-square) analysis for each outcome were entered into the mul-
tivariate analysis. The model was constructed with a backward stepwise
method and then was tested with a forward stepwise method. The propor-
tional hazard assumption was checked by including the interaction term be-
tween metabolic syndrome and other covariates in this model. Odds ratios
(ORs) and confidence intervals (CIs) were then calculated. P< 0.05 was
considered to indicate an independent risk factor and all reported P values
are 2 tailed. All statistical analyses were performed using SPSS version
14.0 for Windows (SPSS Inc, Chicago, Ill).
RESULTS
Patient Characteristics
Of the 1183 consecutive patients who had isolated CABG
during the study period, 551 (46.6%) met the metabolic syn-
drome criteria at the time of CABG and 632 (53.4%) didThe Journal of Thoracic andnot. Comparisons of baseline characteristics and operative
variables between the 2 groups are shown in Table 1. The av-
erage age of the study population was 60 years. Most pa-
tients having CABG were nonobese men who were treated
with nitrates and had multivessel coronary artery disease
with normal left ventricular systolic function. Diabetes
was present in 20.9% of patients at the time of CABG; all
of these cases were type 2 diabetes. When compared with
the nonmetabolic syndrome group, the metabolic syndrome
group had higher proportions of patients with diabetes and
greater use of calcium channel blockers and angiotensin-
converting enzyme inhibitors for hypertension. Patients
with metabolic syndrome were less likely to have CKD
(P ¼ .07). In addition, as expected, patients with metabolic
syndrome exhibited significantly higher BMI, fasting blood
glucose, triglycerides, and blood pressure and lower HDL
cholesterol. No differences between the 2 groups were ob-
served for any other characteristics.
Outcomes
The results of univariate analysis assessing the relation-
ship between metabolic syndrome and incidence of adverse
postoperative outcomes are shown in Table 2. The incidence
of stroke and ARFwas markedly higher in patients with met-
abolic syndrome than in those without metabolic syndrome.
However, there were no differences between the 2 groups in
the incidence of other outcomes.
Stroke
Overall, incidence of stroke was 3.3%. Table 3 shows the
characteristics of patients with postoperative stroke and
ARF. The predictors of stroke with a P value<0.25 were
metabolic syndrome, age, left ventricular ejection fraction,
history of cerebrovascular accident, CKD, peripheral arterial
disease, cardiopulmonary bypass time, and postoperative
low-output syndrome. Interestingly, there were no differ-
ences between patients with and without stroke in terms of
individual components of metabolic syndrome.
The results of multivariate logistic regression analysis are
shown in Table 5. The presence of metabolic syndrome was
an independent predictor of stroke (OR: 2.47, 95% CI:
1.22–4.99, P ¼ .012). The other independent risk factors
for stroke were history of cerebrovascular accident, age,
and cardiopulmonary bypass time.
ARF
The incidence of postoperative ARF was 2.4% in patients
not on preoperative dialysis. A total of 7 variables—meta-
bolic syndrome; older age; male gender; lower left ventricu-
lar ejection fraction; history of cerebrovascular event, CKD,
hypertension, peripheral arterial disease, and postoperative
low output syndrome—were selected by univariate analysis
(Table 4) of ARF.Cardiovascular Surgery c Volume 137, Number 3 659
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Metabolic syndrome (n ¼ 551) No metabolic syndrome (n ¼ 632) P value
Age (y), mean  SD 59  8 59  9 .36
Male (%) 460 (84) 535 (85) .63
Three-vessel disease, n (%) 381 (69) 427 (68) .57
Left main coronary stenosis  50%, n (%) 60 (11) 81 (13) .32
Unstable angina, n (%) 85 (15) 101 (16) .81
Previous cardiac surgery, n (%) 5 (0.9) 2 (0.3) .26
Emergency surgery, n (%) 13 (2.3) 18 (2.8) .60
Left ventricular ejection fraction (%), mean  SD 63.1  13.5 62.5  13.6 .40
Congestive heart failure, n (%) 3 (0.5) 4 (0.6) 1.00
Body mass index (kg/m2), mean  SD 24.4  2.5 22.7  2.3 <.0001
Diabetes mellitus, n (%) 179 (33) 95 (15) <.0001
Fasting blood sugar (mean  SD) 116  34 103  30 <.0001
Hypertension, n (%) 210 (38) 176 (28) <.0001
COPD, n (%) 1 (0.2) 5 (0.8) .22
Peripheral vascular disease, n (%) 24 (4.5) 24 (3.8) .66
Cerebral vascular disease, n (%) 35 (6.4) 34 (5.4) .54
Chronic kidney disease, n (%) 170 (31) 227 (36) .07
Preoperative dialysis, n (%) 12 (2.2) 7 (1.1) .17
Preoperative IABP, n (%) 5 (0.9) 7 (1.1) .78
Systolic blood pressure (mm Hg), mean  SD 132  18 127  17 <.0001
Diastolic blood pressure (mm Hg), mean  SD 77  12 74  12 <.0001
LDL cholesterol (mg/dL), mean  SD 148.1  47.0 152.7  48.8 .101
HDL cholesterol (mg/dL), mean  SD 37.6  10.4 47.2  13.2 <.0001
Triglycerides (mg/dL), mean  SD 213.0  112.0 141.9  95.1 <.0001
Current smoker, n (%) 398 (72) 453 (72) .84
Preoperative medications
Nitrates, n (%) 510 (93) 581 (92) .82
ACE inhibitors, n (%) 21 (3.8) 15 (2.4) .002
Beta blockers, n (%) 242 (44) 222 (35) .02
Calcium antagonists, n (%) 296 (54) 200 (32) <.0001
Aspirin, n (%) 214 (39) 264 (42) .31
Total bypass time (min), mean  SD 158  84 159  57 .92
Use of LITA, n (%) 285 (54) 311 (52) .54
Distal anastomoses (mean  SD) 2.5  0.8 2.4  0.8 .50
Reexploration for bleeding, n (%) 10 (1.8) 12 (1.9) 1.0
Hospital stay (d), mean  SD 26.8  23.0 28.0  23.3 .38
ACE, Angiotensin II converting enzyme; COPD, chronic obstructive pulmonary disease; HDL, high-density lipoprotein; IABP, intra-aortic balloon pump; LDL, low-density
lipoprotein; LITA, left internal thoracic artery; SD, standard deviation.On multivariate logistic regression analysis, the presence
of metabolic syndrome was strongly associated with in-
creased incidence of postoperative ARF (OR: 3.81, 95%
CI: 1.42–10.3, P ¼ .008). Preoperative CKD, peripheral ar-
tery disease, and postoperative low output syndrome were
also independent predictors of ARF (Table 5).
DISCUSSION
Metabolic syndrome has recently received attention as
a cluster of cardiovascular disease risk factors comprising in-
sulin resistance, obesity, hypertension, and dyslipidemia.5 It
is highly prevalent in patients requiring CABG1,2 and af-
fected 47% of patients having CABG in this study. The
present study demonstrated that the preoperative presence
of metabolic syndrome is an independent predictor of
postoperative stroke and ARF. Several risk factors for post-660 The Journal of Thoracic and Cardiovascular Suoperative stroke6-9 and ARF10-12 after CABG have been
established. In addition, several cohort studies have revealed
that metabolic syndrome is associated with increased risk of
stroke13 and renal dysfunction14-16 in the general population.
However, the impact of preoperative metabolic syndrome in
terms of post-CABG complications has been less docu-
mented. The present study is a large observational report
aiming to evaluate the relationship between metabolic syn-
drome and postoperative adverse outcomes following
CABG.
Increased numbers of high-risk patients requiring CABG
results in greater prevalence of comorbidities and complica-
tions following CABG. The prevalence of metabolic syn-
drome is also increasing,17 and this would be expected to
elevate morbidity among patients requiring CABG. We
therefore hypothesized that metabolic syndrome wouldrgery c March 2009
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CABG.
The incidence of stroke following CABG is reported to be
as high as 1% to 6%, and its mortality rate is 25%.6 Post-
operative stroke is an expensive and severe complication
of CABG with prolongation of hospital stay6-9 and poor
prognosis.
Although metabolic syndrome patients have increased
prevalence of conventional risk factors for postoperative
stroke, metabolic syndrome might also increase the risk of
postoperative stroke in other ways. The essential etiologic
mechanism of metabolic syndrome is accepted to be insulin
resistance, which is an independent risk factor for cardiovas-
cular disease and causes endothelial dysfunction with ten-
dencies toward thrombosis and inflammation.3 Endothelial
dysfunction is the first step in atherosclerosis and might po-
tentially contribute to the development of cerebrovascular
disease. In addition, prothrombotic status promotes cardio-
vascular disease. Patients with metabolic syndrome exhibit
elevation of coagulation factors, including fibrinogen, von
Willebrand factor, plasminogen activator inhibitor-1, factor
VIII, and tissue plasminogen activator.3 Elevated fibrinogen
level is an independent risk factor for cardiovascular disease,
and increased levels of vonWillebrand factor are reported to
be associated with occurrence of ischemic stroke in the gen-
eral population.18 Moreover, the preoperative presence of
certain specific genetic polymorphisms for interleukin-6
and C-reactive protein is strongly related to the incidence
of postoperative stroke.19 This supports the notion that pre-
operative tendency toward inflammation is associated with
postoperative stroke. In patients with metabolic syndrome,
this proinflammatory tendency, including elevated cyto-
kines (tumor necrotic factor-alpha and interleukin-6) and
C-reactive protein,3 might also contribute to the develop-
ment of postoperative stroke.
Several epidemiologic studies have examined the associ-
ation between metabolic syndrome and risk of stroke in the
general population. Among 10,357 participants in the Third
National Health and Nutrition Examination Survey, meta-
bolic syndrome, as defined by NCEP-ATP III criteria, was
associated with a 2.2-fold increased prevalence of stroke.20
TABLE 2. Comparison of in-hospital outcomes based on the presence
or absence of metabolic syndrome
Metabolic
syndrome
No metabolic
syndrome
P
value
In-hospital death (%) 1.5 0.9 .44
Stroke (%) 4.7 2.1 .014
Acute renal failure (%) 3.9* 1.1* .003
Myocardial infarction (%) 2.7 3.5 .51
Respiratory insufficiency (%) 22 21 .57
Mediastinitis (%) 2.2 1.1 .49
New onset of atrial fibrillation (%) 16 13 .32
*Patients on preoperative dialysis were excluded.The Journal of Thoracic and CA prospective study of 3298 stroke-free community resi-
dents with a 6.4-year follow-up period yielded similar re-
sults; in multivariate Cox proportional-hazard models,
metabolic syndrome was associated with increased hazard
of stroke (hazard ratio 1.5).21 These findings could be ex-
plained by the fact that intracranial atherosclerosis is associ-
ated with lower levels of adiponectin, a protein secreted by
adipose cells, in patients with metabolic syndrome; these re-
duced levels of adiponectin might be linked to ischemic
stroke in patients with metabolic syndrome.18 These find-
ings support the present finding that metabolic syndrome in-
creases the risk of postoperative stroke.
In addition, the present study suggests that the individual
components of metabolic syndrome are not associated with
TABLE 3. Characteristics of patients with postoperative stroke
Stroke
(n ¼ 39)
No stroke
(n ¼ 1144)
P
value
Metabolic syndrome (%)* 67 46 .014
Serum HDL cholesterol
levels<40 mg/dL for
men,<50 mg/dL for
women (%)
59 47 .14
Serum triglyceride
levels  150 mg/dL (%)
56 51 .52
Fasting blood sugar  100
mg/dL (%)y
56 51 .52
Blood pressure  130/
85 mm Hg (%)z
77 71 .47
Body mass
index  25 kg/m2 (%)
28 27 .56
Age (mean  SD)* 63  7 59  9 <.0001
Gender, male (%) 87 84 .82
Left ventricular ejection
fraction (mean  SD)*
59  16 62  13 .15
History of cerebrovascular
accident (%)*
33 4.9 <.0001
Chronic kidney
disease (%)*
13 5.7 .075
Diabetes mellitus (%) 26 23 .70
Hypertension (%) 38 32 .49
Peripheral arterial
disease (%)
10 3.8 .069
Acute coronary
syndrome (%)
21 16 .38
Cardiopulmonary bypass
time (min)
168  57 159  71 .35
Aortic crossclamp
time (min)
89  32 88  33 .99
Postoperative atrial
fibrillation (%)
10 15 .64
Postoperative low output
syndrome (%)*
7.7 3.1 .13
HDL, High-density lipoprotein; SD, standard deviation. *Variables selected into the
multivariate analysis because P< .25 other than components of metabolic syndrome.
yPatients with normal blood pressure receiving treatment with antihypertensive med-
ication were included. zPatients with normal fasting blood glucose levels treated with
oral hypoglycemics or insulin were included.ardiovascular Surgery c Volume 137, Number 3 661
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be recognized as a novel and important risk factor for post-
operative stroke, independent of its individual components.
Postoperative ARF is another life-threatening complica-
tion of CABG. The incidence of ARF following cardiac sur-
gery ranges from 1% to 30% and its mortality rate was
reported to be 15% to 30%.10-12 The risk factors of postop-
erative ARF include preoperative renal dysfunction, age,
presence of peripheral artery disease, and poor left ventricu-
lar systolic function.10-12 However, the present study found
no differences in incidence of each of these risk factors
between patients with and without metabolic syndrome. In-
stead we found that metabolic syndrome independently
increases the risk of postoperative ARF in patients having
CABG.
Insulin resistance and hyperinsulinemia, considered fun-
damental pathogenic factors in metabolic syndrome, are
TABLE 4. Characteristics of patients with postoperative acute renal
failure
ARF
(n ¼ 28)
No ARF
(n ¼ 1164)
P
value
Metabolic syndrome (%)* 75 45 .003
Serum HDL cholesterol
levels<40 mg/dL for men,
<50 mg/dL for women (%)
57 46 .34
Serum triglyceride
levels  150 mg/dL (%)
71 50 .035
Fasting blood sugar  100
mg/dL (%)y
43 50 .45
Blood pressure  130/85
mm Hg (%)z
89 69 .034
Body mass index  25
kg/m2 (%)
43 23 .024
Age (mean  SD)* 63  8 59  8 .008
Gender, male (%)* 75 83 .19
Left ventricular ejection
fraction (mean  SD)*
58  13 63  14 .073
History of cerebrovascular
accident (%)*
11 5.3 .20
Chronic kidney disease (%)* 68 31 <.0001
Diabetes mellitus (%) 21 23 1.0
Hypertension (%)* 43 32 .23
Peripheral arterial disease (%)* 18 3.5 .003
Acute coronary syndrome (%) 21 16 .43
Cardiopulmonary bypass
time (min)
169  57 158  71 .33
Aortic crossclamp time (min) 92  33 89  32 .54
Postoperative atrial
fibrillation (%)
18 14 .58
Postoperative low output
syndrome (%)*
18 2 .002
ARF, Acute renal failure; HDL, high-density lipoprotein; SD, standard deviation.
*Variables selected into the multivariate analysis because P< .25 other than compo-
nents of metabolic syndrome. yPatients with normal blood pressure receiving treat-
ment with antihypertensive medication were included. zPatients with normal fasting
blood glucose levels treated with oral hypoglycemics or insulin were included.662 The Journal of Thoracic and Cardiovascular Sureported to directly affect renal function by worsening renal
hemodynamics through multiple mechanisms including
sodium retention, activation of the sympathetic nervous
system, decreased Naþ, Kþ-ATPase activity, and elevation
of glomerular filtration fraction.14 These mechanisms could
explain the present association of metabolic syndrome and
postoperative ARF.
Several epidemiologic studies have revealed the relation-
ship between metabolic syndrome and incidence of CKD in
the general population. The Hisayama Study examined risk
of CKD conferred by metabolic syndrome in 1440 Japanese
subjects14; in multivariate analysis, metabolic syndrome was
an independent risk factor for CKD (hazard ratio 2.08). The
Third National Health and Nutrition Examination Survey
showed that metabolic syndrome was associated with
a 2.6-fold increased risk of CKD.15 In a prospective cohort
study, patients with metabolic syndrome had a 1.4-fold
greater risk of CKD when compared with those without
metabolic syndrome.
Although the detailed mechanisms underlying the strong
association between preoperative presence of metabolic syn-
drome and postoperative incidence of ARF after CABG are
unclear, the above findings in the general population support
the results of this study.
Pimenta and colleagues22 documented that the preopera-
tive presence of metabolic syndrome was not related to the
in-hospital adverse outcomes in 107 patients having
CABG. However, the present study assessed a larger sam-
ple, and the impact of metabolic syndrome was evaluated
more thoroughly. In addition, Echahidi and associates1,2
recently reported that the preoperative presence of metabolic
syndrome is associated with postoperative mortality and
new onset of atrial fibrillation after CABG. Although we
did not find increased mortality or new-onset atrial fibrilla-
tion associated with metabolic syndrome, the present study
determined that the presence of metabolic syndrome in-
creased the risk of other postoperative complications,
namely stroke and ARF, after CABG.
Interestingly, Dennis and colleagues23 documented the
impact of the ‘‘deadly quartet,’’ which was a clustering of
TABLE 5. Results of multivariate analysis of risk factors for
postoperative stroke and acute renal failure
OR (95% CI) P value
Stroke
Metabolic syndrome 2.47 (1.22–4.99) .012
History of cerebrovascular incidents 9.52 (4.50–20.2) <.0001
Age 1.08 (1.03–1.13) .001
Cardiopulmonary bypass time 1.01 (1.00–1.01) .024
Acute renal failure
Metabolic syndrome 3.81 (1.42–10.3) .008
Chronic kidney disease 16.0 (6.45–39.8) <.0001
Peripheral artery disease 4.85 (1.49–15.8) .009
Postoperative low output syndrome 5.99 (1.60–22.4) .008
OR, Odds ratio; CI, confidence interval.rgery c March 2009
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was established, in 6428 patients havingCABG.They reported
that the presence of thedeadly quartetwasassociatedwithpost-
operative midterm mortality. We also recently reported that
metabolic syndrome was an increased risk for long-term mor-
tality afterCABG.24Thus, thepresence ofmetabolic syndrome
has a large impact on adverse outcomes, not only immediately
after surgery, but also over the long term.
This study has several limitations. It was a post hoc inves-
tigation and did not address in detail the etiologic mecha-
nisms of stroke. Moreover, treatment in this study differed
in some respects from that in current use—for instance,
cardiopulmonary bypass is not currently used in all cases
of CABG, with arterial grafts being more prevalent, and
perioperative medications and eligibility for surgical revas-
cularization have changed. Moreover, we did not address
intra- and postoperative serum glucose levels in this study.
The present study identified obesity on the basis of BMI, as
waist circumference measurements were not available. How-
ever, studies have demonstrated concordance between a diag-
nosis of metabolic syndrome based on BMI and that based on
waist circumference.25,26 We selected a BMI  25 kg/m2 as
the cutoff point for obesity based on the results of a previous
study on the relationship betweenBMI, visceral fat area, waist
circumference, and obesity in a Japanese population.4 If waist
circumstance had been used to define obesity in the detection
of metabolic syndrome, more specific results might have been
obtained. This study is also limited by a lack of data on the
progression of each risk factor in metabolic syndrome. More-
over, patients were racially homogeneous (almost all were
Japanese), and all were treated at the same institution.
In conclusion, this study represents a large-scale evalua-
tion of the relationship between metabolic syndrome and
postoperative outcomes after CABG. It demonstrated that
metabolic syndrome predicted an increased incidence of
postoperative stroke and ARF. Our findings suggest that
components of metabolic syndrome should be treated
aggressively, even though they may be mild risk factors
when considered individually. We should recognize meta-
bolic syndrome as a novel risk factor for postoperative stroke
and ARF, similar to other established risk factors for postop-
erative complications.
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